Company Diamyd Medical AB Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 4,970,500 | 0 | 0 | 68.13 % |
Stock B | 1 | 1,437,876 | 0 | 0 | |
Stock C | 0 | 13,701,726 | 13,701,726 ( 100.00 %) | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- MERT A Stock
- Stock
- Company Diamyd Medical AB